Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Creative Medical Technology Acquires 80% of BioDefense, Inc.

PUBLIC · CELZSep 25, 2026

Acquiring Company

Creative Medical Technology Holdings

Acquired Company

BioDefense

PhoenixPiedmontBiotechnologyHealth CareBiotechnologyHealth CarePublic Safety

Description

On September 24, 2026, Creative Medical Technology Holdings, Inc. entered into a Stock Purchase Agreement with Creative Acquisition Corp. to acquire 4,000,000 shares of BioDefense, Inc. for $200,000 in cash and 1,000,000 shares of its common stock. Following the transaction, Creative Medical Technology owns 80% of the outstanding shares of BioDefense. This acquisition strengthens its position in the biotechnology sector.

Company Information

Company

Creative Medical Technology Holdings

Location

Phoenix, Arizona, United States

About

Creative Medical Technology Holdings, Inc. is a biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, gynecology, and orthopedics. The company specializes in regenerative medicine solutions and is traded on NASDAQ under the ticker symbol CELZ. Their proprietary procedures aim to provide innovative, non-surgical solutions for chronic pain management.

Fundz sees it the moment Creative Medical Technology Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Donald
Likely contact at this company
••••••••@••••••••

See Donald's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Creative Medical Technology Holdings's next move

Learn about Strategic plan

Frequently asked

Who acquired BioDefense?

BioDefense was acquired by Creative Medical Technology Holdings, based in Phoenix. The deal was reported on September 25, 2026. Creative Medical Technology Holdings, Inc. Creative Medical Technology Holdings is publicly traded (CELZ) and operates in Biotechnology.

When did Creative Medical Technology Holdings acquire BioDefense?

Creative Medical Technology Holdings's acquisition of BioDefense was reported on September 25, 2026. On September 24, 2026, Creative Medical Technology Holdings, Inc. entered into a Stock Purchase Agreement with Creative Acquisition Corp. to acquire 4,000,000 shares of BioDefense, Inc. for $200,000 in cash and 1,000,000 shares of its common stock. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does BioDefense do?

BioDefense, Inc. is a company focused on developing defense technologies and products aimed at enhancing safety and health. It specializes in innovative solutions to protect against biological threats and other health risks. It is privately held, operating in Biotechnology, and is based in Piedmont.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.